SLCO1A2 and cancer: It is worth noticing that cancer cells live in a state of increased basal oxidative stress, which makes them vulnerable to further ROS insults induced by exogenous agents [179–181] Therefore, microcystin analogues can selectively kill OATP expressing cancer cells without causing significant toxicity to normal cells, by exploiting the redox difference between normal and cancer cells.